Management of nonfunctioning islet cell tumors

Table 5 Survival of patients with NFICC

Patients	n	5-yr	10-yr	Median
		survival (%)	survival (%)	survival (mo)
ALL cases	28	58.05	29.03	60 ± 4.35
Male	5	40.00	20.00	45 ± 21.92
Female	23	63.49	31.75	120 ± 44.05
≤ 30 yr	14	54.17	36.11	120 ± 64.02
> 30 yr	14	57.69	0	101
D1 ≤ 10 cm	18	67.57	49.05	101
D1 > 10 cm	10	36.00	0	60 ± 21.75
PD2	7	71.43	35.71	101 ± 56.73
STRP3	1 4	72.00	36.00	120 ± 44.94
PO4	7	0	0	24 ± 3.19

¹Diameter of the cancer,

²Pancreatoduodenectomy,

³Subtotal resection of pancreas,

⁴palliative operation.